In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets.

Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, 401 Barker Hall, Berkeley, CA 94720, USA.
Cell (Impact Factor: 33.12). 01/2006; 123(7):1241-53.
Source: PubMed

ABSTRACT Transcriptional dysregulation has emerged as a potentially important pathogenic mechanism in Huntington's disease, a neurodegenerative disorder associated with polyglutamine expansion in the huntingtin (htt) protein. Here, we report the development of a biochemically defined in vitro transcription assay that is responsive to mutant htt. We demonstrate that both gene-specific activator protein Sp1 and selective components of the core transcription apparatus, including TFIID and TFIIF, are direct targets inhibited by mutant htt in a polyglutamine-dependent manner. The RAP30 subunit of TFIIF specifically interacts with mutant htt both in vitro and in vivo to interfere with formation of the RAP30-RAP74 native complex. Importantly, overexpression of RAP30 in cultured primary striatal cells protects neurons from mutant htt-induced cellular toxicity and alleviates the transcriptional inhibition of the dopamine D2 receptor gene by mutant htt. Our results suggest a mutant htt-directed repression mechanism involving multiple specific components of the basal transcription apparatus.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Protein adsorption is an effective method for the separation of proteins and hence widely accepted in biotechnological applications. The adsorption characteristics of a heme protein, myoglobin (Mb) on a newly developed adsorbent, poly(2-methylpropenoic acid–copolymerized-ethylenesulfonic acid)–grafted–magnetic nanocrystalline cellulose composite [P(MAA-co-VSA)-g-MNCC] was studied. Fourier transform infrared spectroscopy, X-ray diffraction, and scanning electron microscopy studies have helped to characterize the adsorbent. The influence of pH and temperature on the swelling behavior of P(MAA-co-VSA)-g-MNCC was investigated. The specific surface area, the point of zero charge, and the amount of acidic functionalities present on the adsorbent surface were estimated. The effects of some external parameters on the adsorption of Mb were also investigated. Different kinetic and isotherm models were used in this study. The regeneration experiments were conducted with 0.3 mmol·kg–1 NH4OH for five cycles with minimal adsorbent loss. The results from the present investigation proved that Mb can be effectively separated from aqueous solutions by means of P(MAA-co-VSA)-g-MNCC.
    Journal of Chemical & Engineering Data 03/2013; 58(5):1329–1339. · 2.05 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We have developed a superabsorbent composite based on cellulose, namely poly(acrylic acid)-modified poly(glycidylmethacrylate)-grafted nanocellulose (PAPGNC), via graft copolymerization technique, and it is well characterized. The adsorption of a globular protein, hemoglobin (Hb), onto PAPGNC was studied by batch-adsorption technique. The optimum pH for Hb adsorption was found to be 6.7, and the adsorption attained equilibrium within 3.0 h. The kinetic data were found to follow pseudo-second-order model, and the equilibrium data were found to agree with the Langmuir isotherm model. The maximum adsorption capacity of PAPGNC was found to be 119.92 mg/g at 30 °C. The adsorption capacity of PAPGNC toward Hb was found to increase with an increase in temperature. Spent adsorbent was effectively degenerated using 0.1 M KSCN solution without a loss in adsorption capacity, even after four cycles. The present investigation shows that PAPGNC can be developed as an efficient adsorbent for the extraction and recovery of Hb from aqueous solutions.
    Industrial & Engineering Chemistry Research 08/2013; 52(32):11016–11028. · 2.24 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The endocannabinoid system (ECS) and the dopaminergic system (DAS) are two major regulators of basal ganglia function. During Huntington's disease (HD) pathogenesis, the expression of genes in both the ECS and DAS is dysregulated. The purpose of this study was to determine the changes that were consistently observed in the ECS and DAS during HD progression in the central nervous system (CNS) and in the periphery in different models of HD and human HD tissue. To do this, we conducted a meta-analysis of differential gene expression in the ECS and DAS using publicly available microarray data. The consolidated data were summarized as observed changes in gene expression (OCGE) using a weighted sum for each gene. In addition, consolidated data were compared to previously published studies that were not available in the gene expression omnibus (GEO) database. The resulting data confirm gene expression changes observed using different approaches and provide novel insights into the consistency between changes observed in human tissue and various models, as well as disease stage- and tissue-specific transcriptional dysregulation in HD. The major implication of the systems-wide data presented here is that therapeutic strategies targeting the ECS or DAS must consider the dynamic changes in gene expression over time and in different body areas, which occur during HD progression and the interconnectedness of the two systems.
    Pharmacology Research & Perspectives. 02/2015; 3(1).